Share

    


Home / Search Results

Search Results

Search Publications

Search Again?

Filter By Content Type

Filter By Topic

ACCC Immuno-Oncology Institute | 1 Chimeric antigen receptor (CAR) T-cell therapy is quickly emerging as a promising new treatment for hematologic malignancies. Like its more broadly used predecessor, immune checkpoint inhibitors, CAR T-cell therapy has the ability to shrink and even eradicate tumors found in patients with acute lymphocytic leukemia, non-Hodgkins lymphoma, and …
ACCC Immuno-Oncology Institute | 1 As the fusion of medicine, bioengineering, and multidisciplinary cancer care has meant new immunotherapies and renewed hope for patients with aggressive hematologic malignancies, chimeric antigen receptor (CAR) T-cell therapy is quickly emerging as one of the most promising treatments for B-cell acute lymphocytic leukemia, lymphoma, and multiple …
The 118th United States Congress, which officially meets from January 3, 2023, through January 3, 2025, is poised to be a case study in 21st century American bipartisanship. Learn more about what is expected to come in healthcare policy in 2023.
PowerPoint Presentation Medicare Updates Shane Mull, MD, MHA, FAAFP, CPC Senior Medical Director Palmetto GBA February 17, 2023 Presenter Notes Presentation Notes Shane Mull, MD, has no relevant financial relationships to disclose. Disclosure of Conflicts of Interest 2 Shane Mull, MD Senior Medical Director Shane.Mull@palmettogba.com …
Coding, Documentation and Compliance for Radiation Oncology Copyright © 2023 RCCS All Rights Reserved / CPT only ® 2022 American Medical Association All Rights Reserved www.RCCSinc.com 1501 Volta Drive, Suite 100, Cedar Park, TX 78641 Evaluation and Management Coding for 2023 NCOA/SCOS 2023 Joint Conference February 17, 2023 Teri Bedard, BA, R.T.(R)(T), CPC Executive Director Client …
Disclo sure s and Co nflict o f In te re st (CO I) Mit ig a tio n Faculty, Sta ff, and Planne rs’ Disclo sure s The fo llowing ind ivid uals have no re le vant financial re lationship s with ine lig ib le comp anie s to d isclose : Kristin Bake r, MD; Te ri Be d ard , BA, RT (R)(T), CPC; Je nnife r Brune lle , Ronnie Crome r, Asutash Gor, MD; Shane Mull, MD; Mahavish …
Andre Harvin teases his keynote at the ACCC 49th Annual Meeting and Cancer Center Business Summit, where he will talk about innovative solutions to streamline pharmacy operations that have saved his healthcare system millions of dollars. One of those innovative solutions—robotic pharmacists.
Microsoft Word - Changing Treatment Paradigms Webinar 2.10.23.docx Changing Treatment Paradigms for Patients with Multiple Myeloma February 10, 2023 | 4:00 PM EST Currently, there is no cure for multiple myeloma, but there are treatment options that can help people with the disease live longer, healthier lives. Stem cell transplant is a standard of care for eligible patients. …
February 7, 2023
ACCC has invited providers across the U.S. to discuss the unique challenges seen in their respective regions and address how the current state of cancer care for patients with chronic lymphocytic leukemia (CLL) may be improved.
IOS 2023 Spring Conference Friday, March 10, 2023 Des Moines Marriott Downtown AGENDA Friday, March 10, 2023 7:30 AM Registration Open, Networking Breakfast in Resource Center 8:20 AM Welcome & Introductions Susannah P. Friemel, MD President, Iowa Oncology Society 8:30 AM All of ME Erin Sullivan President, After Cancer-Solutions for Sexual Health …
January 17, 2023 Representative Brad Barrett, Chair House Public Health Committee 200 West Washington Street Room 156-A Indianapolis, IN 46204 Dear Chairman Barrett and Members of the House Public Health Committee, The Association for Clinical Oncology (ASCO) and the Indiana Oncology Society (IOS) are pleased to support HB 1017: Prescription Drug Donation Repositories. IOS …
Welcome! Matt Devino, MPH Director of Cancer Care Delivery & Health Policy Association of Community Cancer Centers Welcome and Opening Remarks @ACCCBuzz #ACCCORM CANCER PROGRAM LEADERSHIP Hospital Presidents CEOs, COOs, CMOs Vice Presidents Department Directors CLINICIANS Medical Radiation Surgical Pharmacy ADMINISTRATION Oncology Program and Practice …
Dr. Andre Harvin previews his keynote address at the upcoming Association of Community Cancer Centers (ACCC) 49th Annual Meeting & Cancer Center Business Summit (AMCCBS).
Kevin Davies, PhD, author of Editing Humanity: The CRISPR Revolution and the New Era of Genome Editing, teases his keynote at the ACCC 49th Annual Meeting and Cancer Center Business Summit, where he will talk about the history of genome technology and its potential to change precision medicine.
February 1, 2023
Join the Rocky Mountain Oncology Society for an informative VIRTUAL webinar on the Treatment Approaches for Patients with Polycythemia Vera. Take a deep-dive into the latest clinical findings and discover methods to enhance patient care with Polycythemia Vera. FACULTY SPEAKER: Amit R. Mehta, MD Clinical Associate, Department of Medicine Duke Hospital Cary, NC AGENDA: Polycythemia Vera – A Brief Primer …
Dr. Kevin Davies previews his opening keynote at the upcoming Association of Community Cancer Centers (ACCC) 49th Annual Meeting & Cancer Center Business Summit (AMCCBS).
January 28, 2023
In its eighth year running, attend the Wisconsin Review of the San Antonio Breast Cancer Symposium (SABCS) and participate in interactive sessions—led by some of the nation's leading breast cancer experts—as they share innovative advances in research and explore how these breakthroughs will impact clinical practice across Wisconsin. Whether you are unable to attend the SABCS in December, are looking …
PowerPoint Presentation SABCS 2022: Precision Medicine and Genomics Update Marina Sharifi, MD, PhD Assistant Professor University of Wisconsin Carbone Cancer Center Disclosures • None Agenda 1. Genomic predictors for adjuvant therapy selection in localized ER+ breast cancer: • Long term outcomes from the TAILORx trial • Does Breast Cancer Index predict benefit …